Background Recent studies have suggested a possible association between respiratory
infection and the use of inhaled corticosteroids (ICS). We aimed to ascertain the risk of upper …

Objectives. To systematically review all available studies on inhaled corticosteroid use and
incident pneumonia in asthma patients. Methods. We performed a literature search from …

Recent studies have suggested that inhaled corticosteroids (ICS) may be associated with
higher risks of tuberculosis and pneumonia in patients with COPD. However, it is not known …

Objective To provide an overview of the risk factors and mechanisms underlying asthma
exacerbations and the role of inhaled corticosteroids (ICSs) in preventing exacerbations …

Aim Studies have linked the use of inhaled corticosteroids (ICSs) to excess pneumonia risk
in chronic obstructive pulmonary disease patients. The risk in asthma patients remains …

Background In clinical trials, the use of inhaled corticosteroids is associated with an
increased risk of pneumonia in people with COPD, but whether the same is true for people …

Purpose This systematic review and meta-analysis was performed to determine the safety of
long-term use of ICS in patients with asthma. Methods A systematic search was made of …

Background Pneumonia is an important cause of morbidity and mortality. COPD patients
using inhaled corticosteroids (ICS) have an increased risk of pneumonia, but less is known …

Background Oral corticosteroid use increases the risk of systemic adverse effects including
osteoporosis, bone fractures, diabetes, ocular disorders and respiratory infections. We …

OBJECTIVE: To assess the association between ICS use and risk of pneumonia and other
respiratory infections in children with asthma. DATA SOURCES: We searched PubMed from …